Wall Street Analysts See a 26.14% Upside in Surgery Partners (SGRY): Can the Stock Really Move This High?

Impact · against what's priced in

The upward revision of earnings estimates and a bullish analyst consensus suggest positive momentum for Surgery Partners. However, the impact is moderate as the stock has already climbed 5.5% over the last month, indicating some of the optimistic sentiment is already reflecting in the price.

SGRY+0.30

No priced-in read yet